Hengrui Medicine Posts Net Profit Growth

Hengrui Medicine Posts Net Profit Growth

导出

摘要 Jiangsu Hengrui Medicine Co.,Ltd.(SH:600276) reported on February 8th that itrecorded sales revenue of RMB3.029 billion and net profit of RMB665.7 million in2009,increasing 26.6% and 57.4% over one year earlier,respectively.Jiangsu Hengrui Medicine Co.,Ltd.,is China’s largest manufacturer ofantineoplastics formulation,with a domestic market share of 12%.It is

出处《China Chemical Reporter》 2010年第4期15-15,共11页 中国化工报导（英文版）

关键词 Jiangsu EARLIER REVENUE FORMULATION PROFIT manufac

分类号 F426.72 [经济管理—产业经济]

引文网络
相关文献

1Sinopec Posts Net Profit of RMB 70 Bin in 2007[J].China's Foreign Trade,2008(1):51-51.
2An Introduction to the Formulation of Chinese EV Standards[J].中国汽车（英文版）,2004(12):14-15.
3A research into the auto-related policies and proposals[J].中国汽车（英文版）,2006(12):11-12.
4Chinese Chemical Players Report Q1 Results[J].China Chemical Reporter,2009(19):10-10.
5ZHANG ZHIPING.The Medicine War[J].Beijing Review,2006,49(46).
6Shandong Haihua Unveils Q1 Loss[J].China Chemical Reporter,2009(17):9-9.
7Laobaixing Medicine Gains Investment[J].投资与合作,2008(11):106-109.
827% Net Profit Growth for 2007 in Juhua[J].China Chemical Reporter,2008(15):9-9.
9Net Profit of Sinopec Spurs Astonishingly in H1[J].China Oil & Gas,2009,16(3):8-11.
10Net Profit of CNOOC Plunges in H1 of 2009[J].China Oil & Gas,2009,16(3):12-15.

China Chemical Reporter

2010年第4期

浏览历史

内容加载中请稍等...

Hengrui Medicine Posts Net Profit Growth

相关作者

相关机构

相关主题

浏览历史